Search Contract Opportunities

Agena Bioscience, Inc.

ID: AD-10051 • State: Florida

Description

The DOH BPHL has a need to purchase Cystic Fibrosis reagents and equipment that are used in the CDC-approved test system. The Department uses the MassARRAY and Agena Bioscience equipment, which has specific reagent compatibility requirements.

In accordance with Chapter 60A-1.045, Florida Administrative Code, the Florida Department of Health, the Bureau of Public Health Laboratories (BPHL) of Jacksonville is requesting authorization to purchase, as a sole source, Cystic Fibrosis reagents and equipment that are used in the CDC-approved test system from Agena Bioscience, Inc.

Background
The Florida Department of Health (DOH), specifically the Bureau of Public Health Laboratories (BPHL) in Jacksonville, is seeking to purchase Cystic Fibrosis reagents and equipment that are essential for use in a CDC-approved test system.

The agency's mission includes ensuring public health through effective laboratory services. This contract aims to enhance their testing capabilities.

Work Details
The contract involves the procurement of Cystic Fibrosis reagents and supplies from Agena Bioscience, Inc., which includes:

1. CFTR v3.0 Panel Set – CPM (10x96) - exclusive manufacturer in the U.S.
2. MassARRAY Clean Resin 28g - necessary for compatibility with existing MassARRAY equipment used by BPHL.

These products are specifically required due to their unique compatibility with the current testing systems employed by the laboratory.

Period of Performance
The specific period of performance is not detailed in the provided information.

Place of Performance
The products will be delivered to the Florida Department of Health, Bureau of Public Health Laboratories located in Jacksonville, Florida.
Show All

Overview

Agency
Department of Health (DOH) Logo Florida Department of Health (DOH) [FL]
Opportunity Type
Agency Decision
Opportunity ID
AD-10051
Version
1
Response Start Date
Aug. 22, 2024
Response Deadline
Aug. 27, 2024 Past Due
Date Posted
Aug. 22, 2024
Last Updated
Aug. 22, 2024
Est. Value Range
Experimental
$500,000 - $1,500,000 (AI estimate)
Agency Distribution
High
Source
Open
On 8/22/24 Department of Health (DOH) in Florida issued Agency Decision Agena Bioscience, Inc. with ID AD-10051 due 8/27/24.

Contacts

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo

Documents

Posted documents for Agena Bioscience, Inc.

Classifications

NAICS
325998 - All Other Miscellaneous Chemical Product and Preparation Manufacturing
PSC
6640 - Laboratory Equipment And Supplies
UNSPSC
41106300 - Polymerase chain reaction PCR and reverse transcriptase polymerase chain reaction RT PCR products

Additional Details

Agency Advertisement Number
EXP2582 AD
Minority Encouraged
false

Similar Active Opportunities